PRWeb: Medical Cancer http://www.prweb.com Latest news releases for Medical Cancer from PRWeb en PRWeb Distribution Newswire http://www.prweb.com/images_v4/prweb_logo_hv2.jpg http://www.prweb.com 200 46 xml@emediawire.com xml@emediawire.com Canonsburg Woman Undergoes Robot-Assisted Weight Loss Procedure at AGH http://www.prweb.com/releases/2009/07/prweb2621214.htm A Pittsburgh area woman has undergone a new, robot-assisted weight loss surgical procedure at Allegheny General Hospital. (PRWeb Jul 10, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2621214.htm

]]> Link Between Migraines and Reduced Breast Cancer Risk Confirmed in Follow-Up Study http://www.prweb.com/releases/migraines/breastcancer/prweb2603784.htm Migraines associated with reduced breast cancer risk. Risk did not differ based on a woman’s age. Migraine triggers irrelevant. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/migraines/breastcancer/prweb2603784.htm

]]> Two Reproductive Factors are Important Predictors of Death from Ovarian Cancer http://www.prweb.com/releases/ovariancancer/07/prweb2610644.htm • Greater number of lifetime ovulations linked to higher risk of death• Earlier age of menarche increases risk of death (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/ovariancancer/07/prweb2610644.htm

]]> New Tools Help Parents Reinforce Anti-Smoking Message http://www.prweb.com/releases/Anti-Smoking/Youth_Smoking_Prevention/prweb2616674.htm Multi-media approach keeps "no smoking" message relevant and fresh. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/Anti-Smoking/Youth_Smoking_Prevention/prweb2616674.htm

]]> The Beacon Hotel in South Beach Provides a 25% Discount to Facebook Users http://www.prweb.com/releases/2009/07/prweb2620764.htm The Beacon Hotel proudly announces the launch of the Facebook Fan Special Offer which provides Facebook Users with a 25% discount on their entire stay bookable through hotel’s web site. The Beacon Hotel is the first amongst South Beach Hotels (www.mybeaconhotel.com) to launch this type of aggressive offer aimed at increasing the reach of their social media community. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2620764.htm

]]> 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer http://www.prweb.com/releases/prostate/bioidentical_hormones/prweb2621594.htm Dr. Randolph Says Bioidentical Testosterone Can Promote Prostate Health (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/prostate/bioidentical_hormones/prweb2621594.htm

]]> Vinomis Introduces Vindure 900 - The Resveratrol-equivalent of Over 100 Bottles of Red Wine Plus Quercetin and Red Wine Grape Extract http://www.prweb.com/releases/2009/07/prweb2621794.htm Vinomis Laboratories today introduced a new super-concentrated dietary supplement based on a 900mg combination of three widely acclaimed ingredients: 98% Pure Resveratrol, Red Wine Grape Extract, and Quercetin in a one-per day tablet.This is the first product to be based on proprietary science developed at Harvard Medical School, and licensed to Vinomis. In addition to the long-term health benefits, over 90% of customers are reporting increased energy, improved endurance, improved mental acuity, improved blood sugar, or weight loss. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2621794.htm

]]> Annapalooza: A Summer Bash to Benefit Neuroblastoma http://www.prweb.com/releases/2009/07/prweb2616124.htm Wheaton native Anna O'Connor is passionate about finding a cure for neuroblastoma. She founded "Anna's Hope" earlier this year to help generate awareness about the disease - an aggressive and deadly form of pediatric cancer that she herself has been battling for seven years. As part of her ongoing campaign to raise money for research, Anna is hosting "Annapalooza" on July 18, from 3 to 9 pm on the grounds of the Community Fellowship Church, 28W240 North Ave., West Chicago, IL 60185. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2616124.htm

]]> Neuroblastoma Families, Medical Experts Gather in Chicago to Share Information, Encouragement http://www.prweb.com/releases/2009/07/prweb2626444.htm In search of hope and the promise of new, more effective treatments, families from all over the world with children suffering from neuroblastoma will convene in Chicago on July 16-19 to interface with medical experts and allied healthcare providers at the Children's Neuroblastoma Cancer Foundation's (CNCF) Seventh Annual Conference, www.nbhope.org. (PRWeb Jul 9, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2626444.htm

]]> Prostate Cancer Treatments Safe Prostate Seed Institute in Dallas Responds to Recent Outcomes in Philadelphia http://www.prweb.com/releases/2009/07/prweb2614804.htm Prostate brachytherapy incident in Philadelphia may have been caused in part by inadequate quality control. (PRWeb Jul 8, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2614804.htm

]]> Frankly Speaking About Cancer with The Wellness Community Becomes Award-Winning Internet Talk Radio Program http://www.prweb.com/releases/2009/07/prweb2614064.htm The Wellness Community has hosted Frankly Speaking About Cancer on the VoiceAmerica Health & Wellness Channel since September of 2008. (PRWeb Jul 8, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2614064.htm

]]> Merrimack Pharmaceuticals Initiates Enrollment in a Phase 1/2 Study of MM-111, a Bispecific Antibody to ErbB2/3 http://www.prweb.com/releases/Merrimack/MM-111/prweb2561474.htm Merrimack Pharmaceuticals' second of five oncology pipeline candidates, MM-111, a bispecific antibody, has entered clinical development. Preclinical studies have demonstrated that the bispecific approach shows antitumor activity in a wide range of tumor types. The current Phase 1/2 study will evaluate the human safety and pharmacokinetics (PK) of MM-111. MM-111 is the first bispecific antibody bindng two different receptors on the same cell to enter clinical development. (PRWeb Jul 6, 2009)

Read the full story at http://www.prweb.com/releases/Merrimack/MM-111/prweb2561474.htm

]]> Upstate HomeCare Expands, Adds Pharmacies http://www.prweb.com/releases/oralmedication/pharmacy/prweb2561764.htm Upstate HomeCare, a home medical services provider specializing in infusion, specialty medication, respiratory and DME services, is expanding. Two new pharmacies in Rochester, NY have opened. One specializes in home infusion therapy and one in oral medication, a new product line for Upstate HomeCare. (PRWeb Jul 3, 2009)

Read the full story at http://www.prweb.com/releases/oralmedication/pharmacy/prweb2561764.htm

]]> Children's Cancer Research Fund® Seventh Annual Time to Fly® Walk/Run Sets Records for Dollars Raised and Participants http://www.prweb.com/releases/2009/07/prweb2595684.htm Family event celebrates the lives of cancer patients and raised $175,000 for the University of Minnesota's cutting-edge pediatric cancer research. (PRWeb Jul 6, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2595684.htm

]]> Metabolic Factors May Play a Role in Risk for Breast Cancer http://www.prweb.com/releases/metabolism/breastcancer/prweb2577874.htm • Weight, diet and exercise affects chance of postmenopausal breast cancer • Blood glucose, triglycerides, blood pressure levels significantly increased risk (PRWeb Jul 1, 2009)

Read the full story at http://www.prweb.com/releases/metabolism/breastcancer/prweb2577874.htm

]]> Possible Benefit from Online Genetic Testing in Lung Cancer http://www.prweb.com/releases/genes/06/prweb2582104.htm • People open to using online genetic tests• Study suggests genetic testing may be beneficial, but many questions remain• Smokers likely to take steps toward quitting after using genetic test (PRWeb Jul 1, 2009)

Read the full story at http://www.prweb.com/releases/genes/06/prweb2582104.htm

]]> New PICC Mimics Nature http://www.prweb.com/releases/r4_Vascular/biomimetic/prweb2596764.htm A novel coating being used on a new peripherally inserted central catheter (PICC) from r4 Vascular mimics the cell layer found on natural tissue surfaces. r4 Vascular designed the catheter to have a biomimetic surface that mimics the natural glycocalyx layer on endothelial tissues. (PRWeb Jul 1, 2009)

Read the full story at http://www.prweb.com/releases/r4_Vascular/biomimetic/prweb2596764.htm

]]> Bisphenol A Implicated in Breast and Prostate Cancer: "Ban It Now," Urges Dr. Kathleen T. Ruddy http://www.prweb.com/releases/2009/07/prweb2590434.htm The Breast Health and Healing Foundation's Founder, Dr. Kathleen T. Ruddy calls for the immediate ban of Bisphenol A in all consumer products. According to Dr. Ruddy, Bisphenol A or BPA is the "smoking gun" linking breast and prostate cancer. Two million tons of BPA are used annually to make a variety of consumer products. (PRWeb Jul 1, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2590434.htm

]]> RainSoft Reacts to EPA Toxic Air Study: 2.2 Million Americans at Increased Risk http://www.prweb.com/releases/2009/07/prweb2596204.htm "As bad as the air is outside our homes, indoor levels of home pollutants are typically 2-5 times higher." -Mark Vance, CMO RainSoft (PRWeb Jul 1, 2009)

Read the full story at http://www.prweb.com/releases/2009/07/prweb2596204.htm

]]> President Obama Spotlights HopeLab as Model of Social Innovation http://www.prweb.com/releases/2009/06/prweb2595124.htm HopeLab's CEO Pat Christen Speaks at White House Event as President Inspires Americans to Support Innovation (PRWeb Jun 30, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2595124.htm

]]> Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc. http://www.prweb.com/releases/2009/06/prweb2534454.htm GIA announces the release of a comprehensive global report on Prescription Drugs market. The global prescription drugs market is witnessing a significant deceleration in growth. Key factors slowing down growth in the global prescription drugs market include economic downturn, increasing number of drugs going off patent, increasing proliferation of generics, falling drug costs, and fewer new drug approvals. On the positive side, the market is experiencing increased demand for biologics, biopharmaceuticals, and pharmacogenomics, which are spearheading growth in the industry. (PRWeb Jun 30, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2534454.htm

]]> Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc. http://www.prweb.com/releases/small_molecule/kinase_inhibitors/prweb2559784.htm GIA announces the release of a comprehensive global report on Small Molecule Kinase Inhibitors market. World market for small molecule kinase inhibitor drugs is projected to reach $16.2 billion by the year 2015. This is primarily driven by the rising interest over the potential of kinase inhibitors in effectively blocking, and modifying protein kinase triggered tumor cell metabolism, proliferation, and DNA damage. Strong growth in the future will be led by expansion of treatment indications in both oncology, and non-oncology disease areas. (PRWeb Jun 30, 2009)

Read the full story at http://www.prweb.com/releases/small_molecule/kinase_inhibitors/prweb2559784.htm

]]> Reduced Hospital Stay in BCIR Ileostomy Surgery http://www.prweb.com/releases/2009/06/prweb2586814.htm With recent advances in the area of BCIR ileostomy Surgery, the Continent Ostomy Program of Olympia Medical Center in Los Angeles, CA under the direction of Dr. Don J. Schiller,MD,FACS, has reduced the hospital stay associated with BCIR ileostomy surgery from 21 days to 14 days. (PRWeb Jun 30, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2586814.htm

]]> New Book is a Crash Course for Cancer Caregivers and Fighters http://www.prweb.com/releases/cancer/survivor/prweb2580014.htm In October of 1999, Angela Peterson's mother was diagnosed with stage 4 colon cancer. She was given three days to live and yet emerged cancer-free in April of 2000. "Healed: A Crash Course in What to Do Spiritually and Practically," reveals the strategies Angela's mother and her caregivers followed to experience victory over a serious illness (http://www.caregiverstrength.com/). (PRWeb Jun 29, 2009)

Read the full story at http://www.prweb.com/releases/cancer/survivor/prweb2580014.htm

]]> Infinite Health Resources Celebrates Four Years, the World's Most Informative Privately Owned Health Resource Center and On-line Health Store http://www.prweb.com/releases/2009/06/prweb2581874.htm Infinite Health Resources will continue to offer unique products and health information as it becomes available from our many contributors. (PRWeb Jun 29, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2581874.htm

]]> California Mesothelioma Law Firm Clapper, Patti, Schweizer & Mason Adds Two New Associates http://www.prweb.com/releases/mesothelioma/attorneys/prweb2583784.htm Clapper, Patti, Schweizer & Mason, a national law firm with a focus on representing mesothelioma victims, has added two associates to help deepen the firm's expertise and resources in asbestos litigation. The additions expand the firm's professional staff to eight attorneys. (PRWeb Jun 28, 2009)

Read the full story at http://www.prweb.com/releases/mesothelioma/attorneys/prweb2583784.htm

]]> New Hope for Dogs Diagnosed with Cancer http://www.prweb.com/releases/2009/06/prweb2582914.htm Good news for dogs and their owners: this month, Pfizer Animal Health Inc. announced that the FDA has for the first time ever approved a cancer drug for canines. (PRWeb Jun 28, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2582914.htm

]]> Prosthetic Cancer Wigs Offered by London-Based Hair Loss Solutions Provider http://www.prweb.com/releases/2009/06/prweb2577894.htm White Cliffs Hair Studio,an international hair loss solutions provider, showcases their innovative FDA-listed prosthetic Cancer wigs. Custom produced for those with medically caused hair loss, such as Alopecia or hair loss due to Cancer treatments, these Cancer wigs can be worn long-term and are undetectable in order to help those who are ill to feel better, which helps them to heal faster. (PRWeb Jun 26, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2577894.htm

]]> 'Science Signaling' to Publish Paper on Therapeutically Targeting ErbB3 to Treat Overexpressed or Mutated Oncogenes Merrimack Pharmaceuticals Chief Scientific Officer Ulrik B. Nielsen is Senior Author http://www.prweb.com/releases/2009/06/prweb2579654.htm This paper describes how the authors used a systems biology approach to highlight ErbB3 as a key node in cancer progression and to design a human monoclonal antibody with a novel mechanism that potently inhibits ErbB3 and may potentially benefit patients not effectively treated by current therapies targeting overexpressed or mutated oncogenes. MM-121 is currently being evaluated in clinical trials. (PRWeb Jun 26, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2579654.htm

]]> Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer http://www.prweb.com/releases/Children_Medicine/Cancer_Research/prweb2580204.htm Finding may have implications for gene's role in other cancers (PRWeb Jun 26, 2009)

Read the full story at http://www.prweb.com/releases/Children_Medicine/Cancer_Research/prweb2580204.htm

]]> APR Enters into Licensing Deal with Abdi Ibrahim for Ondansetron Rapidfilm® in Turkey http://www.prweb.com/releases/2009/06/prweb2573014.htm Abdi Ibrahim Pharmaceuticals ("Abdi Ibrahim") and APR Applied Pharma Research SA ("APR"), together with its joint venture partner Labtec GmbH ("Labtec"), today announced that they have entered into an exclusive licensing agreement under which Abdi Ibrahim has the exclusive rights to market Ondansetron Rapidfilm® in Turkey. (PRWeb Jun 26, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2573014.htm

]]> Forsyth Medical Center's Derrick L. Davis Forsyth Regional Cancer Center to Take Part in Research Trial for Patients with Fast-Growing Brain Tumors http://www.prweb.com/releases/2009/06/prweb2568974.htm The Derrick L. Davis Forsyth Regional Cancer Center at Forsyth Medical Center is one of the first sites in the country to participate in a national trial of the experimental drug Avastin to treat glioblastoma, a fast-growing tumor of the brain or spinal cord. This third phase of the trial will test the effectiveness of Avastin in conjunction with standard chemotherapy and radiation treatments for patients newly diagnosed with glioblastoma. This phase of the trial will enroll 700 participants nationwide. (PRWeb Jun 25, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2568974.htm

]]> Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians http://www.prweb.com/releases/medical-transcription/mxsecure/prweb2570764.htm Medical Transcription Services Company MxSecure, Inc. Announces Top Ten Dictation Tips for Physicians: Technique, technology: powerful partners for creating high quality medical transcriptions. (PRWeb Jun 25, 2009)

Read the full story at http://www.prweb.com/releases/medical-transcription/mxsecure/prweb2570764.htm

]]> World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc. http://www.prweb.com/releases/nanomedicine_biomaterials/drug_delivery/prweb2493834.htm GIA announces the release of a comprehensive global report on Nanomedicine markets. The global Nanomedicine market continues to register robust growth largely fueled by unique properties of nanoparticles that provide novel and improved advantages, introduction of novel products, healthy rise in funding across the globe, and increased hype around nanotechnology. (PRWeb Jun 25, 2009)

Read the full story at http://www.prweb.com/releases/nanomedicine_biomaterials/drug_delivery/prweb2493834.htm

]]> Lip Ink® International Qualifies Specialty Retailers for Sales and Distribution of the World's Only Guaranteed Smearproof Semi- Permanent 24-7 Lip Color http://www.prweb.com/releases/semi-permanent/eco-friendly/prweb2569654.htm Lip Ink Specialty Retail Program available for the first time for mass retail. (PRWeb Jun 25, 2009)

Read the full story at http://www.prweb.com/releases/semi-permanent/eco-friendly/prweb2569654.htm

]]> Biomarkers Predict Brain Tumor’s Response to Therapy http://www.prweb.com/releases/cancerresearch/braintumor/prweb2547114.htm • MRI and blood biomarkers predict benefit of antiangiogenic therapy• Greater blood vessel normalization associated with longer survival• Patients with the 25 percent highest normalization lived about a year longer (PRWeb Jun 24, 2009)

Read the full story at http://www.prweb.com/releases/cancerresearch/braintumor/prweb2547114.htm

]]> West Penn Hospital Named Winner of 2009 Premier Award for Quality http://www.prweb.com/releases/2009/06/prweb2562394.htm Premier healthcare alliance has once again recognized The Western Pennsylvania Hospital for its commitment to outstanding patient care and operational efficiency. West Penn is one of just 23 hospitals in the country and the only healthcare provider in the region to win Premier’s 2009 Award for Quality (AFQ). (PRWeb Jun 24, 2009)

Read the full story at http://www.prweb.com/releases/2009/06/prweb2562394.htm

]]> New Jersey Plastic Surgeon, Dr. Paul M. Parker, Encourages Self Screening for Skin Cancer Prevention http://www.prweb.com/releases/skin/care/prweb2570204.htm The most common type of cancer in the United States, skin cancer, is also one of the most treatable if caught early. Dr. Paul M. Parker, a board certified New Jersey plastic surgeon (http://www.parkercenter.net) and member of the American Society for Plastic Surgery (ASPS) offers ways to screen and detect potential problem spots. (PRWeb Jun 24, 2009)

Read the full story at http://www.prweb.com/releases/skin/care/prweb2570204.htm

]]> Journal Publishes AssisTek Article on Best Practices in Electronic Patient Reported Outcomes (ePRO) http://www.prweb.com/releases/epro-clinical-trials/epro-article/prweb2571304.htm As a result of assisTek's commitment to quality systems and expertise in implementing electronic patient reported outcomes (ePRO) in clinical trials, assisTek's article on challenges and best practices for implementing ePRO will be published this summer in EPC Data Management & IT Solutions. (PRWeb Jun 24, 2009)

Read the full story at http://www.prweb.com/releases/epro-clinical-trials/epro-article/prweb2571304.htm

]]> Children's National Medical Center Honors The Children's Cancer Foundation for Commitment to Area Kids http://www.prweb.com/releases/Childrens_National/Shirley_Howard/prweb2568334.htm Children's National Medical Center on Thursday honored the Children's Cancer Foundation for its support of the Center for Cancer and Blood Disorders at Children's National over the past 20 years, giving $3.6 million during that time. (PRWeb Jun 24, 2009)

Read the full story at http://www.prweb.com/releases/Childrens_National/Shirley_Howard/prweb2568334.htm

]]>